首页> 外文期刊>European Heart Journal - Case Reports >Cardiac sarcoidosis presenting with syncope and rapidly progressive atrioventricular block: a case report
【24h】

Cardiac sarcoidosis presenting with syncope and rapidly progressive atrioventricular block: a case report

机译:表现为晕厥和快速进行性房室传导阻滞的心脏结节病:一例报告

获取原文
           

摘要

Background Cardiac sarcoidosis (CS) accounts for a substantial morbidity and mortality. Early recognition of CS is important to prevent such detrimental consequences. A definite diagnosis of cardiac sarcoidosis remains challenging. Even after the diagnosis of CS is established, the appropriate dose and duration of corticosteroids in the treatment of CS have not been well-defined. Case summary In this report, we discuss a case of a 50-year-old man who presented with recurrent syncope. Electrocardiogram revealed sinus rhythm with left bundle branch block. Telemetry captured high-grade atrioventricular block. Coronary angiogram showed no coronary artery disease. Left ventriculography revealed left ventricular ejection fraction (LVEF) of 35–40%. A dual-chamber pacemaker was implanted. Cardiac magnetic resonance revealed mid-myocardial scarring suggestive of sarcoidosis. Computed tomography of the chest showed lymphadenopathy. Transbronchial biopsy was unrevealing; however, mediastinoscopy and lymph node biopsy showed non-caseating granulomas diagnostic of sarcoidosis. He became pacemaker dependent as noted in outpatient pacemaker interrogations. A biventricular implantable cardioverter-defibrillator upgrade was performed for primary prevention of sudden cardiac death. He was started on prednisone taper over the course of 6?months. After 1-year, his LVEF improved to 55% and native atrioventricular (AV) conduction had recovered as noted in outpatient device interrogations. Discussion This case highlights the importance to include CS in the differential diagnosis of a young patient with conduction system disease and non-ischaemic cardiomyopathy for appropriate treatment. Patients with left ventricular systolic dysfunction and AV nodal disease could potentially benefit from a slow prednisone taper over the course of 6?months.
机译:背景心脏结节病(CS)导致大量的发病和死亡。 CS的早期识别对于防止此类有害后果很重要。对心脏结节病的明确诊断仍然具有挑战性。甚至在确定了CS的诊断后,还没有明确确定皮质类固醇在CS治疗中的适当剂量和持续时间。病例总结在本报告中,我们讨论了一个50岁的男性患者,该男性患者出现反复性晕厥。心电图显示窦性心律,左束支传导阻滞。遥测捕获了高级房室传导阻滞。冠状动脉造影未显示冠状动脉疾病。左心室造影显示左心室射血分数(LVEF)为35–40%。植入了双腔起搏器。心脏磁共振显示心肌中部瘢痕形成结节病。胸部计算机断层扫描显示淋巴结肿大。经支气管活检未发现。然而,纵隔镜检查和淋巴结活检显示非干酪性肉芽肿可诊断结节病。如门诊患者对心脏起搏器的询问所述,他成为起搏器的依赖者。进行了双室植入式心脏复律除颤器升级,以预防心脏猝死。他在6个月的时间内开始使用泼尼松锥度治疗。一年后,他的左室射血分数提高到55%,并且自然的房室传导恢复了,如在门诊设备询问中所指出的。讨论该病例强调了将CS纳入对年轻的传导系统疾病和非缺血性心肌病的患者进行鉴别诊断以进行适当治疗的重要性。左心室收缩功能障碍和AV结节病的患者可能会在6个月的时间里因泼尼松逐渐减量而受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号